Theravance Biopharma (NASDAQ: TBPH)
Theravance Biopharma Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Theravance Biopharma Company Info
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
News & Analysis
Why Theravance Biopharma Stock Dived 16% Today
The biotech is not enjoying a winning streak with its pipeline drugs.
Here's Why Theravance Biopharma Stock Is Tanking Today
The company's second clinical-trial flop in as many months isn't sitting well with investors.
Why Theravance Biopharma Shares Are Sinking Today
Investors didn't like the drugmaker's pricing of a planned public stock offering.
Will Theravance Biopharma Finally Break Out in 2020?
Despite achieving several milestones over the past two years, the stock’s response has been muted.
Why Theravance Biopharma Inc Shares Tumbled 19.5% Today
Theravance Biopharma announced a stock and debt offering that disappointed investors.
Theravance Biopharma Inc Skyrocketed in October -- Here's Why
A slew of good news sends shares skyward. So what was announced that got investors so excited?
Why Theravance Biopharma Inc. Fell 20% in September
Despite releasing some good news, a rough month for biotech stocks in general crushed the company's stock.
Why Theravance Biopharma Inc Shares Soared Today
Theravance Biopharma announced that Mylan Inc. has agreed to co-develop TD-4208 and make an equity investment in the company.
Valuation
Earnings Transcripts
Theravance Biopharma, inc (TBPH) Q3 2021 Earnings Call Transcript
TBPH earnings call for the period ending September 30, 2021.
Theravance Biopharma, inc (TBPH) Q2 2021 Earnings Call Transcript
TBPH earnings call for the period ending June 30, 2021.
Theravance Biopharma Inc (TBPH) Q1 2021 Earnings Call Transcript
TBPH earnings call for the period ending March 31, 2021.
Theravance Biopharma Inc (TBPH) Q4 2020 Earnings Call Transcript
TBPH earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.